{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:10:26Z","timestamp":1779099026771,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04383-6","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:41:58Z","timestamp":1751521318000},"page":"301-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Morroniside ameliorates experimental autoimmune encephalomyelitis by regulating gut microenvironment, immune balance, and NF-\u03baB neuroinflammatory pathway"],"prefix":"10.1007","volume":"399","author":[{"given":"Taotao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaopeng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"1","key":"4383_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/nmt-2021-0058","volume":"13","author":"M Amin","year":"2023","unstructured":"Amin M, Hersh CM (2023) Updates and advances in multiple sclerosis neurotherapeutics. Neurodegener Dis Manag 13(1):47\u201370. https:\/\/doi.org\/10.2217\/nmt-2021-0058","journal-title":"Neurodegener Dis Manag"},{"key":"4383_CR2","doi-asserted-by":"publisher","first-page":"105896","DOI":"10.1016\/j.fitote.2024.105896","volume":"175","author":"MS Bhuia","year":"2024","unstructured":"Bhuia MS, Chowdhury R, Ara I, Mamun M, Rouf R, Khan MA et al (2024) Bioactivities of morroniside: a comprehensive review of pharmacological properties and molecular mechanisms. Fitoterapia 175:105896. https:\/\/doi.org\/10.1016\/j.fitote.2024.105896","journal-title":"Fitoterapia"},{"key":"4383_CR3","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.jtauto.2019.100032","volume":"3","author":"SN Choile\u00e1in","year":"2020","unstructured":"Choile\u00e1in SN, Kleinewietfeld M, Raddassi K, Hafler DA, Ruff WE, Longbrake EE (2020) CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. J Translational Autoimmunity 3:100032. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100032","journal-title":"J Translational Autoimmunity"},{"issue":"32","key":"4383_CR4","doi-asserted-by":"publisher","first-page":"22269","DOI":"10.18632\/oncotarget.25170","volume":"9","author":"A Consonni","year":"2018","unstructured":"Consonni A, Cordiglieri C, Rinaldi E, Marolda R, Ravanelli I, Guidesi E et al (2018) Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats. Oncotarget 9(32):22269\u201322287. https:\/\/doi.org\/10.18632\/oncotarget.25170","journal-title":"Oncotarget"},{"issue":"4","key":"4383_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4383_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jemt.1070320305","volume":"32","author":"MC Dal Canto","year":"1995","unstructured":"Dal Canto MC, Melvold RW, Kim BS, Miller SD (1995) Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler\u2019s murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32(3):215\u2013229. https:\/\/doi.org\/10.1002\/jemt.1070320305","journal-title":"Microsc Res Tech"},{"key":"4383_CR7","doi-asserted-by":"publisher","first-page":"1513599","DOI":"10.3389\/fimmu.2025.1513599","volume":"16","author":"X Deng","year":"2025","unstructured":"Deng X, Gong X, Zhou D, Hong Z (2025) Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis. Front Immunol 16:1513599. https:\/\/doi.org\/10.3389\/fimmu.2025.1513599","journal-title":"Front Immunol"},{"issue":"2","key":"4383_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/s1474-4422(20)30432-4","volume":"20","author":"G Fadda","year":"2021","unstructured":"Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B (2021) Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. The Lancet Neurology 20(2):136\u2013149. https:\/\/doi.org\/10.1016\/s1474-4422(20)30432-4","journal-title":"The Lancet Neurology"},{"key":"4383_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cells10113177","volume":"10","author":"S Fischer","year":"2021","unstructured":"Fischer S, Proschmann U, Akg\u00fcn K, Ziemssen T (2021) Lymphocyte counts and multiple sclerosis therapeutics: between mechanisms of action and treatment-limiting side effects. Cells 10:11. https:\/\/doi.org\/10.3390\/cells10113177","journal-title":"Cells"},{"key":"4383_CR10","doi-asserted-by":"publisher","first-page":"104800","DOI":"10.1016\/j.msard.2023.104800","volume":"76","author":"A Hatem","year":"2023","unstructured":"Hatem A, El Ayoubi NK, Habahbeh M, Ghanim Z, Al-Naqshbandi M, Raki A et al (2023) Current and future trends in multiple sclerosis management: near east perspective. Mult Scler Relat Disord 76:104800. https:\/\/doi.org\/10.1016\/j.msard.2023.104800","journal-title":"Mult Scler Relat Disord"},{"issue":"12","key":"4383_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Cree BAC (2020) Treatment of multiple sclerosis: a review. Am J Med 133(12):1380\u20131902. https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.049","journal-title":"Am J Med"},{"issue":"11","key":"4383_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen N, Magyari M (2021) Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol 17(11):676\u2013688. https:\/\/doi.org\/10.1038\/s41582-021-00556-y","journal-title":"Nat Rev Neurol"},{"issue":"18","key":"4383_CR13","doi-asserted-by":"publisher","first-page":"9699","DOI":"10.1073\/pnas.93.18.9699","volume":"93","author":"SY Lee","year":"1996","unstructured":"Lee SY, Lee SY, Kandala G, Liou ML, Liou HC, Choi Y (1996) CD30\/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. Proc Natl Acad Sci USA 93(18):9699\u20139703. https:\/\/doi.org\/10.1073\/pnas.93.18.9699","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"4383_CR14","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1523\/jneurosci.1156-20.2020","volume":"40","author":"Z Lei","year":"2020","unstructured":"Lei Z, Yue Y, Stone S, Wu S, Lin W (2020) NF-\u03baB activation accounts for the cytoprotective effects of PERK activation on oligodendrocytes during EAE. J Neurosci: Off J Soc Neurosci 40(33):6444\u20136456. https:\/\/doi.org\/10.1523\/jneurosci.1156-20.2020","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"4383_CR15","doi-asserted-by":"publisher","unstructured":"Li M, Zhang J, Jiang L, Wang W, Feng X, Liu M et al (2023) Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson\u2019s disease via inhibiting oxidative stress and ferroptosis. BMC Complement Med Ther 23(1):218. https:\/\/doi.org\/10.1186\/s12906-023-03967-0","DOI":"10.1186\/s12906-023-03967-0"},{"key":"4383_CR16","doi-asserted-by":"publisher","first-page":"2402547","DOI":"10.1080\/19490976.2024.2402547","volume":"16 1","author":"N Li","year":"2024","unstructured":"Li N, Han X, Ruan M, Huang F, Yang L, Xu T et al (2024) Prebiotic inulin controls Th17 cells mediated central nervous system autoimmunity through modulating the gut microbiota and short chain fatty acids. Gut Microbes 16 1:2402547. https:\/\/doi.org\/10.1080\/19490976.2024.2402547","journal-title":"Gut Microbes"},{"key":"4383_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms241612912","volume":"24","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza E, Matute C (2023) Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. Int J Mol Sci 24:16. https:\/\/doi.org\/10.3390\/ijms241612912","journal-title":"Int J Mol Sci"},{"key":"4383_CR18","doi-asserted-by":"publisher","first-page":"115568","DOI":"10.1016\/j.biopha.2023.115568","volume":"167","author":"N Mohebali","year":"2023","unstructured":"Mohebali N, Weigel M, Hain T, S\u00fctel M, Bull J, Kreikemeyer B et al (2023) Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating\u00a0Treg\/Th17 cell balance and intestinal barrier integrity. Biomed Pharmacother = Biomed Pharmacotherapie 167:115568. https:\/\/doi.org\/10.1016\/j.biopha.2023.115568","journal-title":"Biomed Pharmacother = Biomed Pharmacotherapie"},{"key":"4383_CR19","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","volume":"19 10","author":"T Moser","year":"2020","unstructured":"Moser T, Akg\u00fcn K, Proschmann U, Sellner J, Ziemssen T (2020) The role of TH17 cells in multiple sclerosis: therapeutic implications. Autoimmun Revi 19 10:102647. https:\/\/doi.org\/10.1016\/j.autrev.2020.102647","journal-title":"Autoimmun Revi"},{"issue":"10","key":"4383_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1248\/bpb.34.1559","volume":"34","author":"CH Park","year":"2011","unstructured":"Park CH, Noh JS, Kim JH, Tanaka T, Zhao Q, Matsumoto K et al (2011) Evaluation of morroniside, iridoid glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db\/db mice. Biol Pharm Bull 34(10):1559\u20131565. https:\/\/doi.org\/10.1248\/bpb.34.1559","journal-title":"Biol Pharm Bull"},{"issue":"18","key":"4383_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijerph18094621","volume":"18","author":"FP Pellizoni","year":"2021","unstructured":"Pellizoni FP, Leite AZ, Rodrigues NC, Ubaiz MJ, Gonzaga MI, Takaoka NNC et al (2021) Detection of dysbiosis and increased intestinal permeability in Brazilian patients with relapsing-remitting multiple sclerosis. Int J Environ Res Public Health 18(18):9. https:\/\/doi.org\/10.3390\/ijerph18094621","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4383_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ncl.2022.05.004","volume":"41","author":"CA P\u00e9rez","year":"2023","unstructured":"P\u00e9rez CA, Cuascut FX, Hutton GJ (2023) Immunopathogenesis, diagnosis, and treatment of multiple sclerosis: a clinical update. Neurol Clin 41(1):87\u2013106. https:\/\/doi.org\/10.1016\/j.ncl.2022.05.004","journal-title":"Neurol Clin"},{"key":"4383_CR23","doi-asserted-by":"publisher","first-page":"110020","DOI":"10.1016\/j.neuropharm.2024.110020","volume":"257","author":"J Pocock","year":"2024","unstructured":"Pocock J, Vasilopoulou F, Svensson E, Cosker K (2024) Microglia and TREM2. Neuropharmacology 257:110020. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110020","journal-title":"Neuropharmacology"},{"key":"4383_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/ijms241612631","volume":"24","author":"D Pukoli","year":"2023","unstructured":"Pukoli D, V\u00e9csei L (2023) Smouldering lesion in MS: microglia, lymphocytes and pathobiochemical mechanisms. Int J Mol Sci 24:16. https:\/\/doi.org\/10.3390\/ijms241612631","journal-title":"Int J Mol Sci"},{"key":"4383_CR25","doi-asserted-by":"publisher","first-page":"623451","DOI":"10.3389\/fimmu.2021.623451","volume":"12","author":"S Ren","year":"2021","unstructured":"Ren S, Zhang X, Guan H, Wu L, Yu M, Hou D et al (2021) Lactobacillus acidipiscis Induced regulatory gamma delta T cells and attenuated experimental autoimmune encephalomyelitis. Front Immunol 12:623451. https:\/\/doi.org\/10.3389\/fimmu.2021.623451","journal-title":"Front Immunol"},{"key":"4383_CR26","doi-asserted-by":"publisher","first-page":"1423062","DOI":"10.3389\/fphar.2024.1423062","volume":"15","author":"P Shi","year":"2024","unstructured":"Shi P, Zheng B, Zhang S, Guo Q (2024) A review of the sources and pharmacological research of morroniside. Front Pharmacol 15:1423062. https:\/\/doi.org\/10.3389\/fphar.2024.1423062","journal-title":"Front Pharmacol"},{"key":"4383_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jaut.2014.11.005","volume":"57","author":"K Shinoda","year":"2015","unstructured":"Shinoda K, Sun X, Oyamada A, Yamada H, Muta H, Podack ER et al (2015) CD30 ligand is a new therapeutic target for central nervous system autoimmunity. J Autoimmun 57:14\u201323. https:\/\/doi.org\/10.1016\/j.jaut.2014.11.005","journal-title":"J Autoimmun"},{"issue":"3","key":"4383_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ane.12712","volume":"136","author":"SP Soelberg","year":"2017","unstructured":"Soelberg SP (2017) Safety concerns and risk management of multiple sclerosis therapies. Acta Neurol Scand 136(3):168\u2013186. https:\/\/doi.org\/10.1111\/ane.12712","journal-title":"Acta Neurol Scand"},{"key":"4383_CR29","doi-asserted-by":"publisher","first-page":"e12866","DOI":"10.1111\/cpr.12866","volume":"53 8","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhu Y, Liu X, Chai Y, Xu J (2020) Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1\/AGE\/RAGE axis. Cell proliferation 53 8:e12866. https:\/\/doi.org\/10.1111\/cpr.12866","journal-title":"Cell proliferation"},{"issue":"4","key":"4383_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0092-8674(88)90079-7","volume":"54","author":"JL Urban","year":"1988","unstructured":"Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J et al (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54(4):577\u2013592. https:\/\/doi.org\/10.1016\/0092-8674(88)90079-7","journal-title":"Cell"},{"key":"4383_CR31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","volume":"11","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar J, Rijvers L, Smolders J, van Luijn MM (2020) B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers. Front Immunol 11:760. https:\/\/doi.org\/10.3389\/fimmu.2020.00760","journal-title":"Front Immunol"},{"issue":"11","key":"4383_CR32","doi-asserted-by":"publisher","first-page":"103449","DOI":"10.1016\/j.autrev.2023.103449","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang J, Feng J (2023) Multiple sclerosis and pregnancy: pathogenesis, influencing factors, and treatment options. Autoimmun Rev 22(11):103449. https:\/\/doi.org\/10.1016\/j.autrev.2023.103449","journal-title":"Autoimmun Rev"},{"key":"4383_CR33","doi-asserted-by":"crossref","unstructured":"Webb LM, Narvaez Miranda J, Amici S A, et al (2019) NF-\u03baB\/mTOR\/MYC axis drives prmt5 protein induction after t cell activation via transcriptional and non-transcriptional mechanisms. Front Immunol 10:524","DOI":"10.3389\/fimmu.2019.00524"},{"key":"4383_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ph16101438","volume":"16","author":"J Xiao","year":"2023","unstructured":"Xiao J, Han Q, Yu Z, Liu M, Sun J, Wu M et al (2023) Morroniside inhibits inflammatory bone loss through the TRAF6-mediated NF-\u03baB\/MAPK signalling pathway. Pharmaceuticals (Basel, Switzerland) 16:10. https:\/\/doi.org\/10.3390\/ph16101438","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"4383_CR35","doi-asserted-by":"publisher","first-page":"105435","DOI":"10.1016\/j.msard.2024.105435","volume":"83","author":"B Yamout","year":"2024","unstructured":"Yamout B, Al-Jumah M, Sahraian MA, Almalik Y, Khaburi JA, Shalaby N et al (2024) Consensus recommendations for diagnosis and treatment of multiple sclerosis: 2023 revision of the MENACTRIMS guidelines. Mult Scler Relat Disord 83:105435. https:\/\/doi.org\/10.1016\/j.msard.2024.105435","journal-title":"Mult Scler Relat Disord"},{"key":"4383_CR36","doi-asserted-by":"publisher","first-page":"155703","DOI":"10.1016\/j.phymed.2024.155703","volume":"129","author":"C Zhang","year":"2024","unstructured":"Zhang C, Tong Q, Liu K, Mao T, Song Y, Qu Y et al (2024) Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy. Phytomedicine 129:155703. https:\/\/doi.org\/10.1016\/j.phymed.2024.155703","journal-title":"Phytomedicine"},{"key":"4383_CR37","doi-asserted-by":"publisher","first-page":"109528","DOI":"10.1016\/j.biopha.2019.109528","volume":"125","author":"D Zhang","year":"2020","unstructured":"Zhang D, Qiao L, Fu T (2020) Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-\u03baB signaling. Biomed Pharmacother 125:109528. https:\/\/doi.org\/10.1016\/j.biopha.2019.109528","journal-title":"Biomed Pharmacother"},{"key":"4383_CR38","doi-asserted-by":"publisher","first-page":"856694","DOI":"10.3389\/fimmu.2022.856694","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang K, Zhang M, Zhang X, Zhang R (2022) Parthenolide suppresses T helper 17 and alleviates experimental autoimmune encephalomyelitis. Front Immunol 13:856694. https:\/\/doi.org\/10.3389\/fimmu.2022.856694","journal-title":"Front Immunol"},{"key":"4383_CR39","doi-asserted-by":"publisher","first-page":"942435","DOI":"10.3389\/fphar.2022.942435","volume":"13","author":"C Zhou","year":"2022","unstructured":"Zhou C, Yao S, Fu F, Bian Y, Zhang Z, Zhang H et al (2022) Morroniside attenuates nucleus pulposus cell senescence to alleviate intervertebral disc degeneration via inhibiting ROS-Hippo-p53 pathway. Front Pharmacol 13:942435. https:\/\/doi.org\/10.3389\/fphar.2022.942435","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04383-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:08:06Z","timestamp":1771538886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04383-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4383"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04383-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols in this study strictly adhered to the Helsinki Declaration and relevant international and domestic ethical guidelines. The use and handling procedures of experimental animals were approved by the Animal Protection and Use Committee of The Second Hospital of Lanzhou University (Approval Number: [D2024-903]). Throughout the research process, we consistently followed the \u201c3R Principles\u201d (Replacement, Reduction, and Refinement) to maximize animal welfare and minimize the number of animals used as well as their suffering. All experimental procedures were performed by professionally trained researchers to ensure the scientific integrity and ethical compliance of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}